SIGRIMA 420MG/14ML INJECTION

SIGRIMA 420MG/14ML INJECTION can affect fertility in some patients, although the extent of this effect is not well-understood. Women who wish to preserve their fertility should discuss their options with their healthcare provider before starting treatment with these drugs.

Yes, SIGRIMA 420MG/14ML INJECTION is often combined with chemotherapy to treat HER2-positive breast cancer. This combination therapy effectively reduces the risk of recurrence and improves overall survival in patients with HER2-positive breast cancer.

If you have active tuberculosis (TB) infection, SIGRIMA 420MG/14ML INJECTION should not be used until the TB infection has been treated and is under control. This drug can suppress the immune system, worsening TB or other infections.

Yes, SIGRIMA 420MG/14ML INJECTION can interact with other medications. It is important to inform your doctor about all the medications, supplements, or herbal products you are taking to avoid potential interactions.

If you are prescribed SIGRIMA 420MG/14ML INJECTION, or any other medication, it is important to carefully read and understand the warnings and precautions associated with the medication. Patients should be monitored for signs of an allergic reaction, such as rash, itching, or swelling, and should seek immediate medical attention if these symptoms occur. It should be used with caution in patients with severe renal impairment. Talk to the physician if you have heart problems, have had radiotherapy, or have allergic conditions. Use effective birth control during the treatment and at least seven months after the last dose. Always maintain a healthy and balanced diet to support your overall health and well-being.

The main molecule in SIGRIMA 420MG/14ML INJECTION is PERTUZUMAB.

SIGRIMA 420MG/14ML INJECTION is used in the treatment of certain types of cancer, particularly HER2-positive breast cancer, often in combination with other therapies.

SIGRIMA 420MG/14ML INJECTION is a targeted therapy that works by blocking the HER2 protein, which is often overexpressed in certain cancers and helps cancer cells grow and divide. By blocking HER2, it helps slow down or stop cancer growth.